TITLE

Alerting patients with artificial heart valves

AUTHOR(S)
Hewes, Patricia A.
PUB. DATE
March 1992
SOURCE
CMAJ: Canadian Medical Association Journal;3/1/1992, Vol. 146 Issue 5, p680
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35470099

 

Related Articles

  • CoreValve gets early approval. Investor's Business Daily // Investors Business Daily;1/21/2014, pA02 

    The artificial heart valve by

  • Acute failure of artificial heart valves. Taylor, Ken // BMJ: British Medical Journal (International Edition);10/22/88, Vol. 297 Issue 6655, p996 

    Focuses on the risk of artificial heart valves. Factors affecting failures of artificial heart valves; Chances of survival for artificial heart failures; Advice for improving the design of artificial valves.

  • The Edinburgh heart valve study. Taylor, K.M. // Heart;Jul2003, Vol. 89 Issue 7, p697 

    Characterizes durability as a performance indicator for artificial heart valves. Types of artificial valves; Design and manufacture of artificial heart valves; Clinical outcome of mechanical valves in comparison to bioprosthetic vales.

  • Tell-Tale Heart. Shine, Barbara // Washingtonian Magazine;Mar2006, Vol. 41 Issue 6, p256 

    Relates the experiences of having an artificial valve transplanted on the heart. Function of the valve; Influence of the valve on the author's perception of life; Comparison of the equipment with the beating of the heart.

  • Heart to Heart.  // Scholastic News -- Edition 3;11/12/2001, Vol. 58 Issue 10, p3 

    Reports on the use of artificial hearts for heart patients.

  • Medtronic Mosaic(R) Heart Valve Demonstrates Long-Term Durability up to 12 Years in International Study.  // Biomedical Market Newsletter;3/21/2011, p196 

    The article reports on the announcement by Medtronic Inc. on the long-term durability of Mosaic(R) bioprosthetic heart valve in a prospective study of patients who had aortic valve replacement (AVR). It says that the Mosaic which is approved by the U.S. Food and Drug Administration (FDA) is an...

  • Fixing a Leaky Valve.  // Time;10/20/1952, Vol. 60 Issue 17, p81 

    The article reports on a heart operation conducted on a 30-year-old woman, who was suffering anginal pain, at the Georgetown University Medical Center in Washington D.C. in which an artificial aortic valve was placed in the patient. Heart surgeon Charles Hufnagel found that placing a substitute...

  • FDA approves first catheter-based artificial heart valve in the U.S. PEDERSEN, AMANDA // Medical Device Daily;11/4/2011, Vol. 15 Issue 212, p1 

    The article reports on the approval granted by the U.S. Food and Drug Administration (FDA) to the transfemoral delivery of the Sapien catheter-based artificial heart valve from Edwards Lifesciences. An overview of the transcatheter aortic valve replacement (TAVR) procedure for aortic valve...

  • Bird Cage in the Heart.  // Time;5/30/1960, Vol. 75 Issue 22, p34 

    The article discusses the heart operation carried out by surgeon Dwight E. Harken to Mary Richardson of Jacksonville, Florida who suffered from two-pronged heart defect. Harken had planned to implant an artificial valve to free Richardson's valve leaflets, however, there had been a difficulty in...

  • Only patients at greatest risk of complications from infective carditis need pre-dental procedure antibiotics.  // Medical Device Daily;6/19/2012, Vol. 16 Issue 116, Special section p2 

    The article informs on the American Heart Association's guideline that only dental patients with a high risk of complications from infective endocarditis including artificial heart valves, congenital heart defects and transplanted hearts should take antibiotics prior to invasive dental procedures.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics